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was as follows: Compared with sham rats, the expressions of collagen I
MI-control rats and the other two admission groups were evidently
increased (P<0.05). Compared with MI-control rats, the expressions
were down-regulated in MI-metoprolol rats and MI-Carvedilol rats.
There were no signiﬁcant differences between MI- metoprolol rats and
MI- carvedilol rats (P>0.05). And also there were no differences be-
tween MI-control rats and MI-small rats (P>0.05). TGF-b1 mRNA
expression is as follows: compared with the sham group (P <0.001)
upregulation of TGF-b1 mRNA in the infarcted myocardium of MI rats
organization. Control group and AMI in the carvedilol group, small dose
of TGF-b1 mRNA is downregulated (P <0.01) in the carvedilol group,
large doses of TGF-b1 mRNA levels close to the small dose of carvedilol
group, two group differences were not signiﬁcant (P> 0.05).
CONCLUSIONS The Carvedilol reduced the infarct zone collagen
molecule synthesis and reducing the synthesis of collagen molecules
in non-infarcted area, effectively retard the process of myocardial
ﬁbrosis as a whole, but no dose-dependent relationship, the mecha-
nism may inhibit the expression of TGF-b1.
GW26-e4353
Angiotensin II Induces Atrial Fibrillation Through STAT3 Mediated Atrial
Structural Remodeling
Liuying Zheng, Xinping Du
The Fifth Central Hospital of Tianjin
OBJECTIVES To determine the role of angiotensin II (Ang II)/Ang II
type 1 (AT1) receptor - stat3 signaling pathway in atrial structural
remodeling.
METHODS Apoptosis of atrial myocytes were measured by TUNEL.
Expressions of phosphorylated stat3, cytochrome C, caspase-3 and
caspase-8 were measured by western blot. Transcripts of collagens
and MMPs were measured by RT-PCR. The association between nu-
clear translocated Stat3 with MMP1 and MMP2 DNA promoter se-
quences was proved by CHIP.
RESULTS In atrial myocytes, incubation with AngII increased level of
apoptosis, expressions of caspase 3 and 8, release of cytochrome C
from mitochondria to cytosol after OGD pretreatment, which was
inhibited by losartan andWP1066. In atrial ﬁbroblasts, incubation with
AngII improved transcriptions of collagenI, collagenIII, MMP1 and
MMP2, which was attenuated by losartan and WP1066. In cultured
atrial myocytes and ﬁbroblasts, Ang II induced tyrosine and serine
phosphorylation of STAT3, It was decreased by losartan and WP1066.
STAT-3 interact with MMP1 and MMP2 DNA promoter sequences in
atrial ﬁbroblasts, the afﬁnity was inhibited by losartan and WP1066.
Rats infused with Ang II exhibited higher levels of apoptosis, collagen
synthesis and phospho-STAT3 in the atria, all of which were attenu-
ated by losartan. In human atrial tissues from patients with atrial
ﬁbrillation, levels of Ang II, percentage of apoptotic cells, synthesis of
collagens and expression of phospho-STAT3 were also elevated.
CONCLUSIONS Ang II/AT1 receptor / STAT3 is an important signaling
pathway in the atrial structural remodeling, Ag-II advance apoptosis
of atrial parenchyma and deposition of atrial ECM, which result in
atrial ﬁbrillation.
GW26-e4720
Toll Like Receptor 9 Deﬁciency Attenuates Pressure Overload Induced
Cardiac Remodeling
Zheng Yang, Qizhu Tang
Renmin Hospital of Wuhan University
OBJECTIVES The Innate immune system may play an important role
in cardiac remodeling. Toll-like receptor 9 (TLR9) is one of the
important components in the innate immune system. However, the
effects and underlying mechanisms of TLR9 in cardiac remodeling are
still unclear. The purpose of this study is to estimate the effects of
TLR9 in cardiac remodeling and try to explore the underlying
mechanisms.
METHODS First, we detected the changes of TLR9 protein level in
different heart issues. Then, TLR9 (-/-) knockout (KO) mice and
C57BL/6 (WT) mice (male, 8 to 10 weeks, 23.5-27.5g weight) were
subjected to aortic banding (AB) operation or Sham as control. And 8
weeks after the surgery, we estimate the role of TLR9 in cardiac
remodeling by echocardiography, pressure-volume (PV) detection,
heart weighing, histological analysis, mRNA expression level analysis.
RESULTS The protein levels of TLR9 were up-regulated in the hearts
after AB, and also ascended in human failing hearts compared with thenormal donors’ hearts. In the estimation of TLR9 regulating cardiac
remodeling, heart weight/ body weight (HW/BW) and heart weight/
tibial length (HW/TL) were elevated after AB, but TLR9 KO mice were
less obvious. Echocardiography and PV results indicated that TLR9 KO
improved left ventricle systolic function and suppressed the left
ventricle dilation. In the histological analysis, HE and PSR stain
demonstrated that TLR9 KO reduces the degrees of cardiomyocytes
hypertrophy and interstitial ﬁbrosis. RT-PCR results showed that the
mRNA levels of some hypertrophic and ﬁbrotic markers, such as ANP,
BNP, b-MHC, CTGF, TGF-b2, Collagen Ia and Collagen III, in TLR9 KO
mice were raised much slightly than WT mice after AB.
CONCLUSIONS By inhibiting cardiac hypertrophy and ﬁbrosis, TLR9
deﬁciency presents a protective effect on cardiac remodeling induced
by pressure overload.
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Lin28a Protects Against Hypoxia/Reoxygenation Induced Cardiomyocytes
Apoptosis by Alleviating Mitochondrial Dysfunction Under High Glucose/
High Fat Conditions
Mingming Zhang, Dongdong Sun, Haichang Wang
Department of Cardiology, Xijing Hospital, Fourth Military Medical
University, Xi’an, China
OBJECTIVES The aim of the present study was to investigate the role
of Lin28a in protecting against hypoxia/reoxygenation(H/R)-induced
cardiomyocytes apoptosis under high glucose/high fat (HG/HF)
conditions.
METHODS Primary cardiomyocytes which were isolated from
neonatal mouse were randomized to be treated with lentivirus car-
rying Lin28a siRNA, Lin28acDNA 72h before H/R (9h/2h). Car-
diomyocytes biomarkers release (LDH and CK), cardiomyocytes
apoptosis, mitochondria biogenesis and morphology, intracellular
reactive oxygen species (ROS) production, ATP content and inﬂam-
matory cytokines levels after H/R injury in high glucose/high fat
conditions were compared between groups. The target proteins of
Lin28a were examined by western blot analysis.
RESULTS Our results revealed that Lin28a cDNA transfection (over-
expression) signiﬁcantly inhibited cardiomyocyte apoptotic index,
improved mitochondria biogenesis, increased ATP production and
reduced ROS production as compared with the H/R group in HG/HF
conditions. Lin28a siRNA transfection (knockdown) rendered the car-
diomyocytes more susceptible to H/R injury as evidenced by increased
apoptotic index, impaired mitochondrial biogenesis, decreased ATP
production and increased ROS level. Interestingly, these effects of
Lin28a were blocked by pretreatment with the PI3K inhibitor wort-
mannin. Lin28a overexpression increased, while Lin28a knockdown
inhibited IGF1R, Nrf-1,Tfam, p-IRS-1, p-Akt, p-mTOR, p-p70s6k,
p-AMPK expression levels after H/R injury in HG/HF conditions.
Moreover, pretreatment with wortmannin abolished the effects of
Lin28a on the expression levels of p-AKT, p-mTOR, p-p70s6k, p-AMPK.
CONCLUSIONS The present results suggest that Lin28a inhibits car-
diomyocytes apoptosis by enhancing mitochondrial biogenesis and
function under high glucose/high fat conditions. The mechanism
responsible for the effects of Lin28a is associated with the PI3K/Akt
dependent pathway.
GW26-e1481
Sphingosine Kinase-2 Protects Against Myocardial Infarction-induced
Heart Failure by Inhibiting Histone Deacetylase Activation
Fuyang Zhang, Yunlong Xia, Shihao Zhao, Wei Wang, Wenjun Yan,
Ling Tao
Department of Cardiology, Xijing Hospital, Fourth Military Medical
University
OBJECTIVES Myocardial infarction (MI) is the leading cause of heart
failure. Persistent histone deacetylase (HDAC) activation in the
myocardium contributes to heart failure progression after MI. Sphin-
gosine kinase-2 (SphK2) and its product sphingosine 1-phosphate (S1P)
have been recognized as endogenous inhibitors of HDAC. However,
the role of SphK2 in the progression of post-MI heart failure remains
unknown.
METHODS MI models were induced by permanent coronary artery
ligation in adult C57bl6 mice. After the operation, ABC294640 (ABC), a
speciﬁc SphK2 inhibitor, was administrated intraperitoneally daily or
until the animal died. The survival conditions of operated-mice were
monitored daily. Left ventricular ejection function was measured by
echocardiography and cardiac remodeling was evaluated by Masson’s
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ducted in the frozen ventricular tissues or in the cultured
cardiomyocytes.
RESULTS SphK2 inhibition signiﬁcantly increased mortality after MI
(Vehicle 20.3% vs. ABC 50.1%). ABC administration obviously exac-
erbated cardiac dysfunction, interstitial ﬁbrosis, and myocardial
apoptosis following MI. SphK2 inhibition upregulated the expression
of remodeling marker genes (ANP, BNP, and b-MHC) in the myocar-
dium. Higher plasma BNP levels in ABC-treated mice indicated more
severe heart failure progression. Compared with vehicle-treated mice,
myocardial HDAC activities were elevated in ABC-treated group. In
the cultured cardiomyocytes, b1 adrenergic receptor agonist-induced
apoptosis and remodeling genes expression were aggravated by
SphK2 knockdown or ABC treatment in the cardiomyocytes, which
was blocked by HDAC inhibitors.
CONCLUSIONS SphK2 and its product S1P exert protective roles in the
remodeling processes and heart failure progression after MI poten-
tially by inhibiting myocardial HDAC activation.
GW26-e0103
CD51 Positive Cardiac Cell Repair the Heart After Myocardial Infarction
Through Transdifferentiation
Wanwen Lin, Chaoquan Peng, Ke Yang, Yang Chen
Department of Cardiology, the Third Afﬁliated Hospital of Sun Yat-sen
University, Guangzhou, China
OBJECTIVES Acute myocardial infarction (AMI) is one of the most
serious diseases that threaten human’s health. AMI may lead to
myocardiolysis, reconstruction and even heart failure. Many experi-
ments demonstrated the potentiality of cardiac stem cells (CSCs) to
treat AMI. They found evidence for enhanced revascularization of the
infarct zone in stem cells-transplanted hearts, and even differentiate
into functional myocytes. A variety of surface markers have been used
to deﬁne CSCs. Until now, we do not virtually know the uniﬁed and
speciﬁc surface markers of CSCs. Recently, the intergrin aV (CD51þ)
are found to express on testicle and myocardial cells. They can pro-
liferate and differentiate into cardiomyocytes and endothelial cells.
The aim of this study was to investigate the effects of CD51 positive
cardiac cells on left ventricular dysfunction or heart failure after AMI.
METHODS CD51 positive cardiac cells were isolated from 7days old
C57BL/6 mice. The cells were labeled by transfected with red ﬂuo-
rescent protein(RFP) before transplant. Wild- type C57BL/6 mice un-
derwent myocardial infarction by ligating the left anterior descending
coronary artery with injection of saline (n¼7), or RFP-CD51þ cardiac
cells (n¼7). Cardiac function was monitored using echocardiography
after 1 week and 4 weeks. The hearts were harvested and frozen at 4w
after cell implantation. Myocardial tissue sections were traced and
stained with immunoﬂuorescence to ﬁnd cells which glowing red
ﬂuorescent and alpha sarcomeric actin positive under ﬂuorescence
microscope.
RESULTS Transplantation of CD51 positive cardiac cells into AMI
mouse hearts improved cardiac function and remodeling, as deter-
mined by echocardiography. Compare with the control group, there
were higher left ventricular ejection fraction (35.9312.09% VS
16.591.88%, p<0.001), shorten fraction (17.306.35% VS 7.510.81%,
p<0.001) and smaller left ventricular end-diastolic volume
(59.7330.84ul VS 118.1641.37ul, p<0.05) in the experimental group
by 1w. The cell treatment group remained signiﬁcantly improved rela-
tive to saline control animals at 4w. The immunoﬂuorescence detection
of cell treatment group showed RFP-CD51þ cells are alpha sarcomeric
actin positive which indicate the transplantation cells can survive in
myocardial infarction regions and differentiate intomature cardiocyte.
CONCLUSIONS The intramyocardial delivery of CD51 positive cardiac
cells after AMI can improve cardiac function, and attenuate remod-
eling at all time points. The in vivo differentiated CD51 positive cells
expressed cardiac markers, as determined by immunohistochemisty.
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Expression of Matrix Metalloproteinase-2 and Mitogen-Activated Protein
Kinases in Ascending Aortic Aneurysms and Aortic Valves of Patients with
Bicuspid or Tricuspid Aortic Valves: a Comparative Study
Chunmao Wang, Xiaogang Sun, Xiangyang Qian, Qian Chang
State Key Laboratory of Cardiovascular Disease, Aorta Surgery Center,
Fuwai Hospital, National Center for Cardiovascular Diseases
OBJECTIVES The objective of this study was to compare the expres-
sion of matrix metalloproteinase-2 (MMP-2) and mitogen-activatedprotein kinases (MAPKs) pathway molecules in ascending thoracic
aortic aneurysms (ATAAs) of patients with bicuspid and tricuspid
aortic valves.
METHODS Ascending aortic aneurysmal wall specimens and valve
samples were taken from tricuspid aortic valves (TAV) patients (n¼20,
51.57.6 years) and tricuspid aortic valves(BAV)patients (n¼20,
47.46.3 years) when surgery repair. Normal ascending aortic speci-
mens (n¼20) were obtained from 20 patients with coronary heart
diseases (CHD) undergoing CABG without aortopathy. MMP-2
expression was examined by qPCR, Western blot in aortic and valve
tissues. MAPKs were measured by Western blot in aortic and valvular
specimens. Some aneurysmal walls were stained with HE and EVG.
RESULTS By histological examination all aortic aneurysm walls
showed TAV aneurysms patients exhibited severe elastin fragmenta-
tion and markedly decreased elastin and much collagen deposition,
compared with BAV aneurysms. Aortas from the BAV group displayed
intact and regular arrayed elastic ﬁbers in the intima and media and
very few collagens. MMP-2 expression was greater in valves and aortic
aneurysm tissues from ATAAs associated with bicuspid valves when
compared with those from tricuspid valves, irrespective of the level of
mRNA and protein (p<0.05). In the aneurysmal wall specimens, t-p38
MAPK was higher in TAV patients than that in BAV patients and CHD
patients (p<0.05). The p-p38 level was also increased in TAV aneu-
rysmal aortic walls compared with BAV group. However, there is no
signiﬁcant difference in t-p38 MAPK between BAV patients and CHD
patients (p>0.05). In addition, t-p38 and p-p38 MAPK levels had also
no signiﬁcant differences between BAV and CHD patients. Addition-
ally, No statistical differences were found in p-ERK1/2, t-ERK1/2 and
p-ERK/t-ERK1/2 between these three groups. Compared with normal
aortic group, p-JNK, t-JNK and p-JNK/t-JNK were increased in two
aneurysmal groups associated with BAV and TAV (p<0.05). Addi-
tionally, the BAV patients have increased levels of t-p54JNK and
p-p54JNK compared with TAV patients. In the valvular tissues, p-p38,
t-p38 and p-p38/t-p38 MAPK were no signiﬁcant differences between
BAV and TAV patients. Additionally, t-ERK1/2 level was higher in TAV
patient than in BAV patient while p-ERK1/2 and p-ERK/t-ERK1/2 levels
had no statistical differences between TAV and BAV patients.
Compared with BAV patients, the levels of p-JNK, t-JNK and p-JNK/t-
JNK were increased in TAV patients (p<0.05).
CONCLUSIONS The up-regulation of MMP-2 in aneurysms associated
with BAV may partly elucidate the predilection to aneurysm forma-
tion in these patients compared with TAV. Furthermore, in the BAV
associated with ascending aortic aneurysms, increased p54JNK level
was found, which may contribute to elucidate the elevated level of
MMP-2 compared with TAV associated with ascending aortic aneur-
ysms.
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Effects of Nerve Growth Factor on Late Reperfusion after Myocardial
Infarction
Yang Liu, Jinhui Wu
Department of Geriatrics, West China Hospital of Sichuan University,
Chengdu, China
OBJECTIVES Nerve growth factor (NGF) is one of the most important
bioactive molecules in nervous system, which involved in neuronal
differentiation, development, repair and adjusting their general
functions. Current studies have demonstrated that NGF plays a pro-
tective role in myocardial infarction and early reperfusion by reducing
the myocardial cell apoptosis and improving ventricular remodeling.
In the study, we investigated the role of nerve growth factor on late
reperfusion by detecting cardiac structure and function with
echocardiography.
METHODS Rats were randomly divided into four groups: Adenoviral
vector group (Adv group, intramyocardial injection, adenoviral vector
10ml in total), NGF overexpression group (NGF group, constructing the
adenovirus vector Ad-NGF containing nerve growth factor gene, 10ul
Ad-NGF as previously described). Sham group and LR group (10ml
normal saline as previously described, respectively). The models of
late reperfusion (LR group, Adv group, NGF group) were established
by ligating the anterior descending branch of coronary artery in
anaesthetized rats, then loosening the ligature after 2 hours, and
starting to reperfusion, the Sham group underwent thoracotomy
without coronary ligation. On the 3th, 7th, 14th and 28th day after
operation, 5 rats in each group were sacriﬁced and their hearts were
harvested. The expression of NGF protein was examined with
immunohistochemisty technology, cardiac structure and function
were measured with echocardiography.
